Trials / Unknown
UnknownNCT04338568
Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study
Accuracy and Inter-observer Variability of Lung Ultrasound in COVID-19 Pneumonia
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Hasselt University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
COVID-19 is a rapidly spreading and very contagious disease caused by a novel coronavirus that can lead to respiratory insufficiency. In many patients, the chest radiograph at first presentation be normal, and early low-dose CT-scan is advocated to diagnose viral pneumonia. Lung ultrasound (LUS) has similar diagnostic properties as CT for diagnosing pneumonia. However, it has the advantage that it can be performed at point-of-care, minimizing the need to transfer the patient, reducing the number of health care personnel and equipment that come in contact with the patient and thus potentially decrease the risk of spreading the infection. This study has the objective to examine the accuracy of lung ultrasound in patients with proven COVID-19 pneumonia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Lung ultrasound | The lung ultrasound examination consists of two-sided scanning of the anterior and lateral chest wall and is performed with patients in supine or near-to-supine position. |
Timeline
- Start date
- 2020-04-16
- Primary completion
- 2020-11-30
- Completion
- 2020-12-30
- First posted
- 2020-04-08
- Last updated
- 2020-08-17
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04338568. Inclusion in this directory is not an endorsement.